The analysts said the Wegovy pills food effect, which prevents patients from eating, drinking or taking other oral medications for 30 minutes after dosing, is likely to limit uptake upon approval of orforglipron and other orals with more convenient profiles. The analysts expect investors to focus on Wegovy pill sales in 2026, especially early in the launch when no true competition exists. BMOs team named data from a head-to-head trial of Novos CagriSema and Eli Lillys tirzepatide, the active ingredient in Mounjaro and Zepbound, expected in early 2026, as another focus of investor interest
Availability varies by region, so discuss referral options with your GP or health visitor
Life-threatening eosinophilic pleuropericardial effusion related to vitamins B5 and H
Researchers warn that addressing TFA contamination will be expensive and difficult, as current filtration systems cannot handle the small, mobile chemical
Recent data from Aon (n=192,000) show that GLP-1 users with 80% adherence experience significantly fewer hospitalizations and lower healthcare costs
